Navigation Links
Survival Benefit With Syndax Pharmaceuticals' Entinostat Maintained in Women with Advanced Breast Cancer
Date:12/7/2011

mestane + placebo HR = 0.58 (95%CI: 0.34, 0.97) p = 0.04
  • Progression-free survival: 4.3 months for exemestane + entinostat vs. 2.3 months for exemestane + placebo HR = 0.73 (95%CI: 0.49, 1.09) p = 0.06; 1-sided significance prospectively defined as  <0.10
  • Progression-free survival of 8.5 months for exemestane + entinostat in subset of patients with increased protein acetylaton vs. 2.8 months in non acetylators HR = 0.32 (95%CI: 0.13, 0.79)
  • Trend in improved progression-free survival in hormone-resistant vs. hormone-sensitive patients
  • Exemestane combined with entinostat was well tolerated with the most frequent adverse events consisting of fatigue, gastrointestinal disturbances and hematologic abnormalities
  • "The continued survival benefit increases our confidence that entinostat will play a critical role in the treatment of women with estrogen receptor-positive metastatic breast cancer," said Joanna Horobin, MD, president and chief executive officer of Syndax.  "We look forward to moving entinostat into phase 3 clinical testing in 2012."

    San Antonio Breast Cancer Symposium
    Presentation Date/Time: Wednesday, December 7 from 5:00 PM - 7:00 PM
    Poster Title: Entinostat, a Novel Histone Deacetylase Inhibitor, Added to Exemestane Improves PFS in Advanced Breast Cancer in a Randomized, Phase II, Double-Blind Study
    Session: POSTER DISCUSSION I: Endocrine Resistance
    Abstract Number: PD01-04
    Location: Ballroom A

    Breast Cancer and Hormone Therapy
    Approximately 230,000 new cases of invasive breast cancer are diagnosed in women annually in the United States and there are approximately 150,000 women living with metastatic breast cancer (MBC).  Over 70 percent of women with breast cancer have estrogen receptor-positive (ER+) breast cancer.  The most effective cancer treatments target the underlying biology and in breast canc
    '/>"/>

    SOURCE Syndax Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
    2. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
    3. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
    4. ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
    5. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
    6. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
    7. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
    8. Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer
    9. Survival Data for Avicenas Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
    10. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
    11. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/19/2014)... 2014 /PRNewswire-iReach/ -- Market Research Report on ... is a professional and in-depth market survey ... The report firstly reviews the basic information ... and manufacturing technology. The report then explores ... Hydrochloride listing their product specification, capacity, Production ...
    (Date:9/19/2014)... 2014 Kiromic, LLC, a Lubbock ... Hance , the former chancellor of Texas Tech University, to ... in July 2014, after raising $1.2 billion for the university. ... Hance , the most successful chancellor in the history of ... as an investor, but also as our new vice chairman ...
    (Date:9/19/2014)... -- 4WEB Medical announces the formal launch of the ... on the market today at this weekend,s American ... Chicago .  The Osteotomy Truss System is a ... 74 size options included in one versatile set. Previously ... to 18 implant sizes, which limited a surgeon,s ability ...
    Breaking Medicine Technology:Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 2Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 3Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 4Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 5Former Texas Tech Chancellor Named New Vice Chairman of the Board of Kiromic, LLC 24WEB Medical Unveils 3D-Printed Osteotomy Truss System 2
    ... PITTSBURGH , July 14 Mylan Inc. ... Pharma Holdings Limited, a privately held, global injectable pharmaceutical company ... provide Mylan not only an immediate entry into the North ... opportunities. This transaction is expected to be accretive to Mylan,s ...
    ... DEERFIELD, Ill. , July 14 ... Metabolic Drugs Advisory Committee and the Drug Safety and ... focused on reviewing the cardiovascular (CV) safety of rosiglitazone, ... two day discussion, Takeda Pharmaceuticals North America, Inc. ("Takeda") ...
    Cached Medicine Technology:Mylan to Acquire Bioniche Pharma Global Injectable Pharmaceuticals Business 2Mylan to Acquire Bioniche Pharma Global Injectable Pharmaceuticals Business 3Mylan to Acquire Bioniche Pharma Global Injectable Pharmaceuticals Business 4Mylan to Acquire Bioniche Pharma Global Injectable Pharmaceuticals Business 5Takeda Responds to FDA Advisory Committee Recommendation 2Takeda Responds to FDA Advisory Committee Recommendation 3Takeda Responds to FDA Advisory Committee Recommendation 4Takeda Responds to FDA Advisory Committee Recommendation 5
    (Date:9/21/2014)... 21, 2014 Hundreds of Risperdal ... in Pennsylvania’s Philadelphia Court of Common Pleas, Bernstein ... proceeding’s next monthly meeting has been scheduled for ... , “Our Firm is representing a number of ... litigation. We are pleased with its continued progress,” ...
    (Date:9/21/2014)... 2014 (HealthDay News) -- Young women starting college understand ... foods they should eat. But they aren,t confident they ... to a new study. The study involved ... Illinois,s Peer Education Exercising and Eating Right program. The ... choose to eat if they were very busy with ...
    (Date:9/21/2014)... 2014 Discount-Dress.com, a company ... recently announced its decision to implement a new shopping ... for ladies across the world. Furthermore, the company has ... ladies. , The new items come in fashionable ... prices, up to 56 percent off. "We are happy ...
    (Date:9/21/2014)... Dallas, TX (PRWEB) September 21, 2014 ... and Chinese Fenofibrate (CAS 49562-28-9) Industry, 2009-2019 ... on Global and Chinese Fenofibrate (CAS 49562-28-9) ... information of Fenofibrate (CAS 49562-28-9) including its ... explores global and China’s top manufacturers of ...
    (Date:9/21/2014)... (PRWEB) September 21, 2014 High in ... teams of disabled and able-bodied athletes rafted the Colorado ... a ropes course in pursuit of outdoor adventure. At ... national non-profit World T.E.A.M. Sports, disabilities proved to be ... successfully completed the three stage event. , Each participating ...
    Breaking Medicine News(10 mins):Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Move Forward in Pennsylvania Litigation, As Court Schedules October Meeting, Bernstein Liebhard LLP Reports 4Health News: College Women Can Use Food Strategies, Study Finds 2Health News:Discount-Dress.com Implements A New Shopping Cart Software And Provides New Beach Wedding Dresses 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 3Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 4Health News:Disabled Athletes Excel at World T.E.A.M. Sports’ Adventure Team Challenge 2Health News:Disabled Athletes Excel at World T.E.A.M. Sports’ Adventure Team Challenge 3
    ... LLC has joined the effort to help relieve ... of Cyclone Nargis. Special donation kiosks,have been developed ... the,virtual world of Second Life, with coordination being ... island,( http://slurl.com/secondlife/Simuality/106/83/41 )., In addition, links to ...
    ... Coalition for Iraq and Afghanistan Veterans Gather in Virginia ... Organizations, CHANTILLY, Va., May 9 As the ... death toll climbs above 4,000 and,casualty numbers approach the ... organizations on the homefront have organized to help,bereaved families ...
    ... disease-resistant gene wards off fusarium wilt on leaves , , ... to helping tomatoes fight a fungus that causes wilt ... there,s an ongoing battle against the ability of plant ... system, according to background information in the study. One ...
    ... demands reap mental benefits regardless of age or ... News) -- Having an intellectually demanding job that ... abilities during retirement, regardless of intelligence, education level ... suggests. , "Our society is expected to live ...
    ... wanted minimally invasive procedure more often, despite drawbacks , , ... be trumping science when it comes to treatments for ... patients are getting a newer, minimally invasive surgery, because ... though there is little data on actual differences in ...
    ... From Bush Administration,s $770 Million Cut to,Medicare-Financed Nursing Home ... the,American Health Care Association (AHCA) and Alliance for Quality ... release and comment on a,new study from The Lewin ... from the Bush Administration,s recently-announced cut of,$770 million to ...
    Cached Medicine News:Health News:Leading Veterans Service Organizations Meet Near Washington May 13-15, 2008 2Health News:Leading Veterans Service Organizations Meet Near Washington May 13-15, 2008 3Health News:Leading Veterans Service Organizations Meet Near Washington May 13-15, 2008 4Health News:Demanding Jobs May Pay Cognitive Dividends in Retirement 2Health News:Newer Prostate Cancer Treatment Similar to Traditional Surgery 2Health News:Newer Prostate Cancer Treatment Similar to Traditional Surgery 3
    ... Plate Shaker are designed to give reliable performance ... microplates. The on/off button, power supply socket and ... of the unit. The speed knob is located ... of speed from a minimum 950 rpm to ...
    ThermoPrep 3's two systems in "one" approach, its capability to accommodate up to two standard microplates and its user-selectable settings offers the versatility and throughput you need in today's l...
    The BD LSR II can be configured with up to four fixed alignment lasers and the ability to detect up to 15 colors, utilizing a revolutionary optical design. The BD LSR II can be configured with a 488 ...
    Modular flow cytometer with all options....
    Medicine Products: